Bret Bernhizer’s 2011 Annual Performance Review. Well folks I have been working on my year end performance review as well as my direct reports for 2011. So that got me to thinking; who does Bret’s annual review? Let’s think about this; he is the CEO, Chairman of the Board and is surrounded by family within the organization. So who challenges Bret’s from a strategy, leadership, product etc.. perspective? My guess is no one! As a shareholder of NNLX, I have decided to evaluate Mr. Bret on his 2011 performance. Below is a CEO review checklist with rating and my comments in bold. Please feel free cut and paste performance and do your own. So; since this board has been as boring as our share price; I am going to try spice things up around here. Please note this is a 2011 review and not a review of Bret’s entire career with NNLX.
RATINGS:
1 – DOES NOT MEET EXPECTATIONS – REQUIRES COACHING
2 – SOMETIMES MEETS EXPECTATIONS – DEVELOPING MANAGER
3 – MEETS EXPECTATION – STRONG PERFORMER
4 – EXCEEDS EXPECTATIONS FREGUENTLY – ABOVE INDUSTRY PEERS
5- EXCEPTIONAL – EXCEEDS EXPECTATIONS CONSITANTLY – INDUSTRY LEADER
• Leadership and excellence in customer fulfillment.
Rating – 2. No customers yet; however for 2011 shareholders are not happy with share price performance.
• Ability to achieve mission and specific board objectives.
Rating – N/A – I don’t know.
• Achieving medium-long term goals and key strategies.
Rating – 3. Bret has done a good job in promoting the products this past year as well as increasing their visibility.
• Ongoing and active communication with all board members and shareholders
Rating – 1. No shareholding meeting, no financial data and information on time line, milestones, strategy etc.
• Acquisition and ultilisation of market intelligence
Rating – 3.
• Attendance to board meetings and activities
Rating – 1. Other than product PR; shareholders are kept in the dark
• Development and management of resources, policies and systems
Rating – 2.
• Statutory reporting and compliance
Rating – 1. Major coaching required
• Ensure long term profit and commercial viability
Rating – 3. Has communicated to has cash for 2 years operations (FDA approval should come before that).
• Forge strong strategic relationships
Rating – 3. I like the additions to the SAB this past year.
• Delegation & authority
Rating – 2. Bret appears to be a micro-manager.
• Demonstration of personal qualities
Rating – 3
Overall Rating – 2.19 - Bret has done a good job this past year in the area a product awareness however given the share price performance is down 23%, as CEO he has not effectively communicated the milestones, FDA strategy and time line, and finally the financials.
AI
